![[Translate to English:]](/fileadmin/_processed_/5/0/csm_Schulte__Dr._Marina_print_8d5f2bc06b.jpg)
Düsseldorf
+49 211 600 55-237 +49 211 600 55-220 m.schulte@heuking.de
Languages
German, English
Practice groups/Expertise
Consulting focuses
- Medical Law
- Law of Medical Practitioners
- Corporate Law
Vita
- Certified Specialist Lawyer in Medical Law since 2021
- Admitted to the Bar since 2012
- Education and former activities
- Associate at D+B Rechtsanwälte Partnerschaft mbB 2020 - 2022
- Senior Associate at Clyde & Co LLP 2019 - 2020
- Senior Associate at Taylor Wessing PartnG mbB 2017 - 2019
- Associate at Taylor Wessing PartnG mbB 2014 - 2017
- Doctorate at the University of Regensburg 2014
- Associate at Noerr LLP 2012 - 2014
- Legal clerkship at the District Court of Mönchengladbach 2010 - 2012
- Law studies at the University of Konstanz 2000 - 2010
Affiliations
- Arbeitsgemeinschaft Medizinrecht im Deutschen Anwaltverein
- Deutscher Anwaltverein e.V. (DAV)
- International Bar Association (IBA
Publications
2022
Informed consent in underage patients - a practice guide part 2
Der Urologe, Vol. 61, Issue 4, April 2022 (only in german available)
Informed consent in underage patients - a practice guideline part 1
Der Urologe, Volume 60, Issue 3, March 2022 (only in german available)
2020
Insurance for clinical trials of medical devices
VersicherungsPraxis 6/2020 (only in german available)
Pitfalls in premium adjustments in private health insurance
Versicherungsmonitor 04/14/2020 (only in german available
Impact of the Covid-19 pandemic on the duty to inform in the context of the treatment contract
ZMGR 04/2020, 199ff. (only in german available)
No trend toward per diem compensation for pain and suffering
Versicherungsmonitor Jan. 28, 2020 (only in german available)
Compensation for pain and suffering: Compensation for treatment errors still appropriate?
GesR 1/2020, 14ff. (only in german available)
Still no trend toward per diem compensation for pain and suffering
Quarterly Update 1/2020 (only in german available)
Thank you for your interest!
We'll get back to you as soon as possible.
We'll get back to you as soon as possible.
An error occured!
Please try again later.
Please try again later.